Useful for identifying the second and third stages in the development of a nutritional deficiency when the tissue stores followed by the body fluids levels become gradually depleted of the nutrient(s)
Some static biochemical tests measure levels of the nutrient in biological fluids and tissues on the assumption that such tests reflect the total body nutrient content or the nutrient tissue store most sensitive to depletion
Show the change of nutrient concentration in any given specimen which is most sensitive to nutritional change
Assess the physiological performance of an individual in vivo such as immune competence, taste acuity, night blindness, muscle function, and work capacity
None of the tests are specific and must be interpreted along with biochemical measurements
Determine the changes in the activities of enzymes dependent on a specific nutrient or in the concentrations of specific blood components dependent on a given nutrient
Assess the consequences of the nutrient deficiency by measuring changes in the activities of a specific enzyme or in the concentrations of specific blood components dependent on a given nutrient
Biological measurements (e.g., in blood or urine) that are used to indicate normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention
Defined as biological characteristics that can be objectively measured and evaluated as indicators of normal biological or patho genic processes, or as responses to nutrition inter ventions
Can be measure ments based on biological tissues and fluids, on physio logical or behavioral functions, and more recently, on metabolic and genetic data that in turn influence health, well-being and risk of disease
Program managers and policymakers use population-level biomarkers for screening, surveillance, and monitoring and evaluation of interventions
Clinicians use biomarkers mainly for diagnosis, prognosis, and treatment; and researchers use biomarkers for any or all of these purposes based on their needs
Measure the extent of the functional con sequences of a nutrient deficiency: serve as early bio markers of subclinical deficiencies
Functional biochemical: enzyme stimulation assays; abnormal metabolites; DNA damage
Functional physio logical/behavioral": more directly related to health status or disease such as vision, growth, immune function, taste acuity, cognition, depression. These biomarkers impact on clinical and health outcomes
Food or nutrient intakes; dietary patterns; sup ple ment usage
Can be based on direct measurements of nutrient intake using traditional dietary assessment methods, or indirect measurements using surrogate indicators termed "dietary bio markers"
Measure ments of concentrations of a nutrient in biological fluids or tissues, or the urinary excretion rate of a nutrient or its metabolite
Biopsy material most frequently used is whole blood or some fraction of blood
Other body fluids and tissues, less widely used, include urine, saliva, adipose tissue, breast milk, semen, amniotic fluid, hair, toenails, skin, and buccal mucosa
Measure the extent of the functional con sequences of a nutrient deficiency
Functional biochemical: enzyme stimulation assays; abnormal metabolites; DNA damage
Functional physio logical/behavioral": more directly related to health status or disease such as vision, growth, immune function, taste acuity, cognition, depression. These biomarkers impact on clinical and health outcomes
Biomarkers are affected by non-biological sources of variation arising from specimen collection and storage, seasonality, time of day, contamination, stability, and laboratory quality assurance
Both biological and non-biological sources of variation will impact the validity, precision, accuracy, specificity, sensitivity, and predictive value of the biomarker
Personnel should use calibrated equipment and standardized, validated techniques which are continuously monitored by appropriate quality-control procedures